brivanib: Clinical Trials

5 trials of brivanib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 4, Terminated 1

Follow brivanib: new trials by email Literature Review of brivanib trials Research Report on brivanib

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment
Brivanib, Placebo - Carcinoma, Hepatocellular
Phase 3TerminatedBristol-Myers Squibb872010-05-012015-10-12
Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC
Brivanib, Brivanib Placebo, TACE Therapy - Hepatocellular Carcinoma
Phase 3CompletedBristol-Myers Squibb7342009-07-202019-12-02
First Line Hepato Cellular Carcinoma (HCC)
Brivanib, Placebo, Sorafenib - Hepato Cellular Carcinoma (HCC)
Phase 3CompletedBristol-Myers Squibb17142009-05-012016-10-17
Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment
Brivanib, Placebo, Best Supportive Care - Liver Cancer
Phase 3CompletedBristol-Myers Squibb5872009-02-172019-10-09
Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer
cetuximab, brivanib alaninate - Colorectal Cancer
Phase 3CompletedNCIC Clinical Trials Group7502008-05-122023-08-04

Conditions studied

Carcinoma, Hepatocellular (2)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Rectal Neoplasms (1)

Sponsors

Bristol-Myers Squibb (4)  ·  NCIC Clinical Trials Group (1)

Countries

Canada (4)  ·  China (4)  ·  South Korea (4)  ·  Taiwan (4)  ·  Argentina (3)  ·  France (3)  ·  Hong Kong (3)  ·  Italy (3)  ·  Japan (3)  ·  Spain (3)  ·  United States (3)  ·  Australia (2)  ·  Belgium (2)  ·  Brazil (2)  ·  Germany (2)

Top investigators

Lillian L. Siu, MD, FRCPC (1)

Results publications

PMID 23690424, PMID 23980084, PMID 23980090, PMID 28131794, PMID 30466310, PMID 34052255, PMID 40215447